Sanofi
Research Sanofi (SNY) on Bullrun: market cap USD 96.92B, dividend yield 6.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSNY
- ExchangeNASDAQ
- CountryFrance
- SectorHealthcare
- IndustryDrug Manufacturers-General
- CurrencyUSD
- Market capUSD 96.92B
- Dividend yield6.1%
- Financial periodQ2 2026
- RevenueEUR 12.30B
- Net incomeEUR 343.00M
- Free cash flowEUR 1.66B
- Gross margin75.5%
Valuation Snapshot
latest market cap is USD 96.92B; dividend yield is 6.1%.
Peer valuation comparison
Latest dividend yield is 6.09% versus a Healthcare sector median of 1.84% (231.0% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 46.72B | EUR 7.81B | EUR 7.21B | 72.1% | 3.19 | EUR 7.66B | EUR 20.33B | EUR 71.38B |
| FY2024 | EUR 44.29B | EUR 5.56B | EUR 5.89B | 70.2% | 2.3 | EUR 7.44B | EUR 17.91B | EUR 77.51B |
| FY2023 | EUR 41.62B | EUR 5.40B | EUR 7.35B | 69.7% | 2.16 | EUR 8.71B | EUR 18.42B | EUR 74.04B |
| FY2022 | EUR 40.56B | EUR 8.37B | EUR 8.42B | 70.7% | 2.69 | EUR 12.74B | EUR 21.21B | EUR 74.78B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 96.92B | n/a | 6.1% | 2.42 |
| 2025 | 2025-12-31 | USD 118.19B | n/a | 4.6% | 2.21 |
| 2024 | 2024-12-31 | USD 120.92B | n/a | 4.2% | 2.04 |
| 2023 | 2023-12-29 | USD 124.72B | n/a | 3.8% | 1.9 |
| 2022 | 2022-12-30 | USD 121.47B | n/a | 4.2% | 2.05 |
| 2021 | 2021-12-31 | USD 125.50B | n/a | 3.8% | 1.91 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 2.42 USD, yield 6.1%.
| Year | Dividends/share |
|---|---|
| FY2025 | 2.21 EUR |
| FY2024 | 2.04 EUR |
| FY2023 | 1.9 EUR |
| FY2022 | 2.05 EUR |
About Sanofi
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection; hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines; and Fluzone, a flu vaccine.
ETFs that hold Sanofi
Sanofi is one of the ten largest holdings of 43 ETFs that investors in Europe can buy. The 8 most traded of them:
| ETF | Weight | TER |
|---|---|---|
| Amundi CAC 40 UCITS ETF Acc | 4.60% | 0.25% |
| Amundi CAC 40 UCITS ETF Dist | 4.60% | 0.25% |
| iShares Edge MSCI Europe Value Factor UCITS ETF EUR (Acc) | 4.16% | 0.25% |
| iShares MSCI EMU CTB Enhanced ESG UCITS ETF EUR Acc | 1.97% | 0.12% |
| AMUNDI CAC 40 ESG UCITS ETF DR - EUR (C) | 5.67% | 0.25% |
| State Street SPDR S&P Euro Dividend Aristocrats UCITS ETF | 3.28% | 0.30% |
| iShares MSCI Europe Health Care Sector UCITS ETF | 5.16% | 0.18% |
| State Street SPDR MSCI Europe Health Care UCITS ETF | 5.30% | 0.18% |
Compare every fund on the same index:
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Sanofi's market cap?
Sanofi's market capitalization is USD 96.92B.
Does Sanofi pay a dividend?
Sanofi has a dividend yield of 6.1%.
What does Sanofi do?
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection; hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines; and Fluzone, a flu vaccine.